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Abstract: Two phenyl ester and three benzyl ester derivatives have been synthesized from 2,6-
di(pyrazol-1-yl)pyridine-4-carboxylic acid and the appropriate phenyl or benzyl alcohol using N,N’-
dicyclohexylcarbodiimide as the coupling reagent. Complexation of the ligands with Fe[BF4]2·6H2O 
in acetone yielded the corresponding [FeL2][BF4]2 complex salts. Four of the new ligands and four 
of the complexes have been crystallographically characterised. Particularly noteworthy are two 
polymorphs of [Fe(L3)2][BF4]2·2MeNO2 (L3 = 3,4-dimethoxyphenyl 2,6-di{pyrazol-1-yl}pyridine-4-
carboxylate), one of which is crystallographically characterised as high-spin while the other exhibits 
the onset of spin-crossover above room temperature. The other complexes are similarly low-spin at 
low temperature but exhibit gradual spin-crossover on heating, except for an acetone solvate of 
[Fe(L5)2][BF4]2 (L5 = benzyl 2,6-di{pyrazol-1-yl}pyridine-4-carboxylate), which exhibits a more abrupt 
spin-transition at T½ = 273 K with 9 K thermal hysteresis. 
Keywords: iron; N-donor ligand; spin-crossover; crystal structure; magnetic measurements 
 
1. Introduction 
Spin-crossover (SCO) compounds are an important class of molecular switches which are widely 
studied in molecular materials chemistry [1–3]. The SCO switching event changes a number of 
physical properties in a material including its colour, magnetic moment [4], volume [5], dielectric 
properties [6–9], conductivity [9–12], and fluorescence [13–15]. Solid or mesophase phase transitions 
and isotropic melting can also be coupled to spin transitions in soft materials containing SCO centres 
[16,17]. Moreover, a material’s SCO switching properties are preserved at the nanoscale in particles 
[18] or thin films [19] above 30–50 nm in diameter (size effects become important at smaller length 
scales) [20]. This has led to SCO centres being incorporated into a variety of functional and 
multifunctional materials and prototype devices [3,21]. A popular family of compounds in spin-
crossover (SCO) research is derived from [Fe(bpp)2]2+ (bpp = 2,6-di{pyrazol-1-yl}pyridine) [22–24]. 
Many functional groups can be appended to the bpp ligand skeleton [25], with predictable 
consequences for the spin state of the coordinated iron atom [26,27]. This flexibility has allowed 
emissive [28–31], photo-isomerizable [32], redox active [33,34], magnetically active [35,36]， and 
metal-binding substituents [31,37–39] as well as surface-binding tether groups [40–42] to be attached 
to the [Fe(bpp)2]2+ framework， giving a variety of multifunctional SCO molecular switches.  
With that in mind， we [43] and others [29,35,36,44–46] have employed 2,6-di(pyrazol-1-yl)-
pyridine-4-dicarboxylic acid [47] as a convenient precursor to new bpp derivatives bearing tether 
groups or other functionalities for SCO research. On our part, we recently reported a family of 2,6-
di(pyrazol-1-yl)pyridine-4-dicarboxylate esters bearing long chain 4-alkoxyphenyl substituents, 
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which are derived from L1 and L2 (Scheme 1). The iron(II) complexes of these (potentially amphiphilic) 
ligands proved to have a varied structural chemistry that depends on the R1 alkoxy chain length. 
Most of the compounds were low-spin around room temperature but underwent SCO on heating. 
Annealing at higher temperatures led to the loss of crystallinity, possibly from disordering of the 
alkoxy chain conformations, which had a strong effect on the metal spin state when the sample was 
recooled [43].  
 
Scheme 1. Ligands referred to in this work. L1, L2 and their iron(II) complexes are described in [43]. 
As a continuation of this work, we describe two new series of 2,6-di(pyrazol-1-yl)pyridine-4-
dicarboxylate esters and their iron complex chemistry. First are two dimethoxy or dihydroxyphenyl 
esters L3 and L4 as models for new derivatives bearing two R2 alkoxy chains per ligand, which may 
increase their amphiphilic character. Second are the first three benzyl 2,6-di(pyrazol-1-yl)pyridine-4-
dicarboxylate esters L5–L7 to examine how additional conformational flexibility in the ester linkage 
affects the structural chemistry of this family of compounds.  
2. Results and Discussion 
2.1. Synthesis 
2,6-Di(pyrazol-1-yl)pyridine-4-carboxylic acid was prepared by the literature route, from 
pyrazole and 2,6-dibromopyridine-4-dicarboxylic acid (Scheme 2) [47]. Refluxing this precursor in 
thionyl chloride converted it in situ to 2,6-di(pyrazol-1-yl)pyridine-4-carbonyl chloride, which was 
then treated with 3,4-dimethoxyphenol to afford L3 in 55% overall yield. Conversion of L3 to L4 was 
achieved in 69 % yield using a ten-fold excess of boron tribromide. Alternatively, reaction of 2,6-
di(pyrazol-1-yl)pyridine-4-carboxylic acid with the appropriate benzyl alcohol, in the presence of the 
coupling agent N,N-dicyclohexyl carbodiimide (DCC) and catalytic 4-(dimethylamino)pyridine 
(DMAP), gave L5–L7 in low-to-moderate recrystallized yields. The identities of all the ligands were 
confirmed by 1H and 13C NMR and HR-ESMS spectrometry, while four of the new ligands were also 
characterised by X-Ray crystallography.  
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Scheme 2. Syntheses of the new ligands. Reagents and conditions: (i) SOCl2, reflux, 12 hr then  
3,4-dimethoxyphenol, dimethylformamide, NEt3, rt, 48 hr. (ii) BBr3, CH2Cl2, ‒78 °C → reflux, 4 hr.  
(iii) Benzyl alcohol, N,N-dicyclohexyl carbodiimide, DMAP (cat), dichloromethane, rt, 48 hr. 
The salts [FeL2][BF4]2 (L3–L7) were obtained by complexing 0.5 equiv of Fe[BF4]2·6H2O by the 
appropriate ligand in acetone, which yielded the products as red or brown microcrystals after the 
usual work-up. All the complexes were solvent-free solids by microanalysis after drying in vacuo, 
except [Fe(L4)2][BF4]2, which contained 2 equiv lattice water. While this solvent is not evident in the 
crystal structure of that complex, the disorder in the crystal (see below) and the hydrogen bonding 
capabilities of the L4 ligand could both facilitate absorption of atmospheric moisture by the bulk 
material. 
2.2. Crystallographic Characterization 
All the new ligands except L4 were crystallographically characterised. The pyridyl and pyrazolyl 
groups in the tris-heterocyclic ligand cores all adopt the anti-coplanar orientation that is typically 
found in crystalline bpp derivatives [48]. This avoids repulsive interactions between the pyridyl N1 
and pyrazolyl N2 lone pairs [49]. The asymmetric units of L5 and L7·½MeCN both contain two 
crystallographically independent ligand molecules (ie Z’ = 2). While the two unique molecules of L5 
have essentially identical conformations, the two molecules of L7 show significantly different torsions 
about their benzyl substituent methylene groups. 
Recrystallization of [Fe(L3)2][BF4]2 from nitromethane/diethyl ether gave mixtures of two crystal 
forms, which were readily distinguished by their dark red and bright yellow colouration and proved 
to be polymorphs of formula [Fe(L3)2][BF4]2·2MeNO2 (Figure 1). Both polymorphs exhibit the triclinic 
space group P1ത  but with significantly different unit cell parameters. Crystals of the major red -
polymorph are low-spin at 120 K according to the metric parameters at the iron atom, while the minor 
yellow -polymorph is high-spin at the same temperature (Table 1). As well as the expanded FeN6 
coordination sphere expected for a high-spin complex [50], the coordination geometry of the -
polymorph is significantly more distorted away from the idealized D2d symmetry expected for this 
ligand combination. This is evident in the trans-N{pyridyl}−Fe−N{pyridyl} angle (), and the dihedral 
angle between the least squares planes of the heterocyclic cores of the two L3 ligands (). Both 
parameters in the -polymorph are close to their idealized values of 180 and 90°, respectively (Table 
1), which is to be expected in low-spin [Fe(bpp)2]2+ derivatives [22]. However, the -polymorph 
exhibits reduced values of 166.41(12)° and 79.90(3)°. Deviations of these parameters from their 
ideal values are common in high-spin compounds [24] and reflect an angular Jahn–Teller distortion 
of the high-spin 5T configuration [51,52]. Since the distortion is only a property of the high-spin 
molecules, distorted molecules must rearrange to a more regular coordination geometry during spin-
crossover, which can be inhibited in a rigid solid lattice. In practice, spin-crossover is rarer in 
complexes exhibiting  < 172° in their high-spin form, as in -[Fe(L3)2][BF4]2·2MeNO2 [53]. 
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Table 1 Metric parameters for the two polymorphs of [Fe(L3)2][BF4]2·2MeNO2 (Å, Å3, º). VOh,  and  
are indices characteristic for the spin state of the complex [50,54], while  and  are defined in the text 
[50]. Typical values of these parameters in [Fe(bpp)2]2+ derivatives are given in [22] and [55]. 
 α-[Fe(L3)2][BF4]2·2MeNO2 β-[Fe(L3)2][BF4]2·2MeNO2 
Fe−N{pyridyl} 1.8903(17), 1.8917(17) 2.143(3), 2.156(4) 
Fe−N{pyrazolyl} 1.9502(19)−1.9831(19) 2.151(3)−2.208(4) 
VOh 9.446(5) 12.357(13) 
 84.6(3) 159.2(4) 
 275 475 
 174.29(8) 166.41(12) 
 89.79(2) 79.90(3) 
 
Figure 1. View of the complex dications in the low-spin -polymorph (top) and high-spin - 
polymorph (bottom) of -[Fe(L3)2][BF4]2·2MeNO2. Displacement ellipsoids are at the 50% probability 
level, and H atoms are omitted. Colour code: C, white; Fe, green; N, blue; O, red. 
Solvent-free crystals of [Fe(L4)2][BF4]2, and acetonitrile solvates of [Fe(L5)2][BF4]2 and 
[Fe(L6)2][BF4]2 were also crystallographically characterised. While not being isostructural, all three of 
these compounds contain two unique complex molecule environments in their asymmetric units (i.e., 
Z’ = 2). Both complex cations in each compound are low-spin at 120 K, with only minor differences 
in their coordination geometries (Table 2). Most notable is molecule B in [Fe(L6)2][BF4]2·3/2MeCN, 
whose inter-ligand dihedral angle [83.18(4)°] is at the low end of the usual range for a low-spin 
[Fe(bpp)2]2+ derivative [22]. This reflects a distorted conformation in ligand N(2B)-C(29B) caused by 
two short intermolecular C‒H… contacts involving benzylic CH2 groups in the lattice (Figure 2). 
The two unique molecules in each crystal differ in the disposition of their ester substituents. One 
dihydroxyphenyl group in molecule B of [Fe(L4)2][BF4]2 is badly disordered, reflecting a steric clash 
with its symmetry equivalent across a crystallographic inversion centre (Figure 3). The disorder 
extends to two BF4− ions (and their symmetry equivalents) which hydrogen bond to this dihydroxy-
phenyl residue. The two cations in [Fe(L5)2][BF4]2·3/2MeCN (Figure 4) and [Fe(L6)2][BF4]2·3/2MeCN 
show less dramatic ligand disorder but have different torsions about their benzylic methylene 
groups. 
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Table 2 Metric parameters for the other crystallographically characterised complexes (Å, Å3, º). 
Compound [Fe(L4)2][BF4]2 [Fe(L5)2][BF4]2·3/2MeCN 
Molecule Molecule A Molecule B Molecule A Molecule B 
Fe−N{pyridyl} 1.897(3), 1.897(3) 1.888(3), 1.898(3) 1.892(2), 1.892(2) 1.890(2), 1.891(2) 
Fe−N{pyrazolyl} 1.956(4)−1.990(4) 1.965(4)−1.977(4) 1.955(2)−1.964(3) 1.953(3)−1.972(3) 
VOh 9.537(11) 9.499(11) 9.392(7) 9.405(8) 
VOh 88.8(5) 84.8(5) 84.3(4) 83.6(4) 
 275 278 276 274 
 176.93(16) 178.09(16) 175.96(11) 178.45(11) 
 85.54(5) 87.63(4) 88.14(3) 87.78(3) 
Compound [Fe(L6)2][BF4]2·3/2MeCN  
Molecule Molecule A Molecule B   
Fe−N{pyridyl} 1.889(3), 1.896(3) 1.891(3), 1.897(3)   
Fe− N{pyrazolyl} 1.965(4)−1.978(3) 1.963(4)−1.996(4)   
VOh 9.501(10) 9.538(11)   
 83.7(5) 90.5(5)   
 277 274   
 176.34(15) 175.93(15)   
 89.77(3) 83.18(4)   
 
Figure 2. Intermolecular C‒H… interactions causing the twisted ligand conformation in molecule 
‘B’ of [Fe(L6)2][BF4]2·3/2MeCN, which is highlighted with dark colouration. Symmetry codes: (i) x, 3/2‒
y, 1/2+z; (ii) 1‒x, 1‒y, 1‒z. Colour code: C, white or dark grey; H, pale grey; Fe, green; N, pale or dark 
blue; O, red. 
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Figure 3. Ligand and anion disorder about a crystallographic inversion centre in molecule ‘B’ of 
[Fe(L4)2][BF4]2. C-bound H atoms are omitted for clarity; other details as for Figure 1. The three 
disorder sites of the dihydroxyphenyl substituents are distinguished with pale, medium, and dark 
colouration. Symmetry code: (iii) ‒x, 2‒y, ‒z. Colour code: C, white, pale or dark grey; H, pale grey; B, 
pink; F, cyan; Fe, green; N, blue; O, pale, medium, or dark red. 
 
Figure 4. The complex dications in [Fe(L5)2][BF4]2·3/2MeCN, showing the orientations of their benzyl 
substituents. Benzyl group disorder sites are distinguished with pale and dark colouration. Other 
details as for Figure 1. Colour code: C, white or grey; Fe, green; N, blue; O, red. 
Lastly, a preliminary structure solution was achieved from a weakly diffracting crystal of 
[Fe(L7)2][BF4]2·nMe2CO·¼H2O (orthorhombic, space group Pna21), which was also clearly low-spin at 
120 K. Interestingly, this crystal also has Z’ = 2, with two unique complex molecules in its asymmetric 
unit. Although a full refinement of that structure was not achieved, the preliminary model was 
sufficient to compare with the powder diffraction data from that compound as described below. 
2.3. Characterization of the Bulk Materials 
The freshly prepared [Fe(L3)2][BF4]2·2MeNO2 was a mixture of the - and -polymorphs, but the 
pure -polymorph could be obtained by decanting off crystals of the -form. X-Ray powder 
diffraction data from -[Fe(L3)2][BF4]2·2MeNO2, [Fe(L4)2][BF4]2, and [Fe(L7)2][BF4]2·nMe2CO·¼H2O at 
298 K showed good agreement with their crystallographic simulations (Figure 5). Hence, these 
compounds retain their structural integrity on exposure to air, despite the tendency of [Fe(L4)2][BF4]2 
to absorb atmospheric moisture. However, [Fe(L5)2][BF4]2·3/2MeCN and [Fe(L6)2][BF4]2·3/2MeCN 
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exhibited additional diffraction peaks on top of their crystallographically characterised phases, which 
may reflect structural changes during solvent loss from those materials under ambient conditions. 
 
Figure 5. Measured (black) and simulated (red, grey) X-Ray powder diffraction data from the 
complexes in this work. No crystallographic simulation is available for [Fe(L5)2][BF4]2·nMe2CO. 
Magnetic susceptibility data from freshly prepared [Fe(L3)2][BF4]2·2MeNO2 showed a constant 
MT value of 1.1 cm3 mol−1 K between 50–100 K (where zero-field splitting effects do not operate), 
implying a ca. 30 % high-spin population at those temperatures (Figure 6). That is consistent with a 
mixture of low-spin - and high-spin -polymorphs, as observed crystallographically. A gradual 
increase in MT on further warming may imply the onset of SCO in -form at higher temperatures. 
This was confirmed by measurement of the purified -polymorph of the complex, which is 
diamagnetic and fully low-spin below 220 K but shows a gradual increase in MT on further heating, 
reaching 0.7 cm3 mol−1 K at 350 K. That is consistent with high-temperature SCO, with T½ > 400 K, from 
extrapolation of the data. This resembles other [Fe(bpp)2]2+ complex salts bearing carboxy 
substituents, which often exhibit SCO significantly above room temperature in the solid state 
[27,36,43–46]. 
Magnetic data from most of the other complexes are similar in being low-spin below 150 K (in 
agreement with their crystal structures) while undergoing gradual SCO with T½ ≥ 350 K. However, 
[Fe(L4)2][BF4]2 shows a low-temperature MT value of 1.6 cm3 mol‒1 K between 50–100 K, implying 
almost 50% of the sample remains high-spin at all temperatures, which is inconsistent with its 
crystallographic data (Table 2). While the sample was phase pure by powder diffraction (Figure 5), it 
also contained lattice water by microanalysis, which is not evident in the crystal structure. That may 
indicate the presence of an amorphous, possibly hydrated, high-spin fraction in the material.  
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Figure 6. Variable temperature magnetic susceptibility data for different preparations of 
[Fe(L3)2][BF4]2·2MeNO2 (left) and [Fe(L5)2][BF4]2 (right), at a scan rate of 5 K min−1. Data for 
[Fe(L3)2][BF4]2·2MeNO2 were measured on a cooling temperature ramp only. 
The other noteworthy material is [Fe(L5)2][BF4]2, which was obtained in two different, 
presumably solvated forms. Crystallographically characterised [Fe(L5)2][BF4]2·3/2MeCN exhibits the 
expected SCO above room temperature with T½ = 370 K (Figure 6). The SCO is monotonic within the 
temperature range of the measurement, showing the two unique molecular environments in the 
crystal undergo SCO at similar temperatures. The transition is also reversible with a narrow thermal 
hysteresis, implying it is barely perturbed by any solvent loss when the sample is heated. However, 
after recrystallization from acetone/diethyl ether, the same complex showed a more abrupt, hysteretic 
spin-transition centred just below room temperature (T½↓ = 269 K, T½↑ = 278 K at a scan rate of 5 K 
min−1). This phase is not isostructural with the MeCN solvate (Figure 5), but since its crystals were 
unsuitable for a crystallographic determination, the structural origin of this enhanced SCO 
cooperativity is presently unclear. 
SCO in [Fe(L3)2][BF4]2 and [Fe(L4)2][BF4]2 was also measured in CD3CN solution by the Evans 
method, which demonstrated almost complete SCO equilibria for both compounds over the liquid 
range of the solvent (Figure 7). Thermodynamic parameters and spin-crossover midpoint 
temperatures were derived from these data by fitting these data to equations 1 and 2, where nHS(T) 
is the high-spin fraction of the sample at temperature T: 
 
Figure 7. Magnetic susceptibility data for [Fe(L3)2][BF4]2 (left) and [Fe(L4)2][BF4]2 (right) in CD3CN 
solution. The lines show the fits of the data to equations 1 and 2. 
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ln[(1‒ nHS(T))/nHS(T)] = ΔH/RT ‒ ΔS/R (1) 
ΔS = ΔH/T½ (2) 
The fitted parameters were T½ = 289.2(4) K, ΔH = 22.0(3) kJ mol‒1, ΔS = 76(2) J mol‒1 K‒1 for 
[Fe(L3)2][BF4]2; and T½ = 292(1) K, ΔH = 20(1) kJ mol‒1, ΔS = 68(3) J mol‒1 K‒1 for [Fe(L4)2][BF4]2. These 
values resemble those of [Fe(L1)2][BF4]2 and [Fe(L2)2][BF4]2 in the same solvent [43] and show the 
hydrogen bonding capability of L4 has little effect on the spin state of its iron complex. While the 
lower entropy of SCO for [Fe(L4)2][BF4]2 could reflect a more rigid, hydrogen bonded solvent shell 
around that complex, this is uncertain since the difference between the two compounds is close to the 
error of the measurement. 
3. Experimental Section 
3.1. Instrumentation 
Elemental microanalyses were performed by the microanalytical services at the University of 
Leeds School of Chemistry, or the London Metropolitan University School of Human Sciences. 
Electrospray mass spectra were recorded on a Bruker MicroTOF-q instrument from CHCl3 solution. 
Diamagnetic NMR spectra employed a Bruker Ascend Advance III spectrometer operating at 400.1 
MHz (1H) or 100.6 MHz (13C), while paramagnetic 1H NMR spectra were obtained with a Bruker 
DPX300 spectrometer operating at 300.1 MHz. X-Ray powder diffraction measurements were 
obtained from a Bruker D2 Phaser diffractometer, using Cu-K radiation ( = 1.5419 Å). 
Magnetic susceptibility measurements were performed using a Quantum Design VSM SQUID 
magnetometer in an applied field of 5000 G with a temperature ramp of 5 K min−1. Diamagnetic 
corrections for the samples were estimated from Pascal’s constants [56], and SCO T½ values were 
estimated as the temperature where MT = 1.75 cm3 mol‒1 K (high-spin complexes of this type typically 
exhibit MT = 3.5 ± 0.1 cm3 mol‒1 K [22]). Susceptibility measurements in solution were obtained by 
Evans method using a Bruker Avance 500 FT spectrometer operating at 500.1 MHz [57,58]. A 
diamagnetic correction for the sample [56], and a correction for the variation of the density of the 
CD3CN solvent with temperature [59], were applied to these data. 
3.2. Synthesis 
2,6-Di(pyrazol-1-yl)pyridine-4-carboxylic acid (bppCOOH) was prepared by the literature method 
[47]. 
3.2.1. Synthesis of 3,4-dimethoxyphenyl 2,6-di(pyrazol-1-yl)pyridine-4-carboxylate (L3) 
A mixture of bppCOOH (1.28 g, 5.0 mmol) and thionyl chloride (10 cm3) was heated at reflux for 
12 hr. The coloured solution was evaporated to dryness, and the resultant 2,6-di(pyrazol-1-
yl)pyridine-4-carbonyl chloride was redissolved in dimethylformamide (DMF, 15 cm3). A mixture of 
3,4-dimethoxyphenol (0.77 g, 5.0 mmol) and triethylamine (20 cm3) in DMF (10 cm3) was added to 
this solution. The reaction was stirred for 48 hr at room temperature, yielding a large quantity of 
precipitate. Water (40 cm3) was added to the stirred reaction mixture, which precipitated the product 
as an off-white solid. The product was collected, washed with water, and dried in vacuo. Yield: 1.08 
g, 55%. Mp: 201–202 °C. HR-ES MS m/z 392.1387 (calculated for [(C20H17N5O4)H]+ 392.1353). 1H NMR 
({CD3}2SO) δ 3.77, 3.79 (both s, 3H, OCH3), 6.70 (dd, 1.7 and 2.4 Hz, 2H, Pz H4), 6.89 (dd, 1H, Ph H6), 
7.03 (d, 1H, Ph H5), 7.08 (d, 1H, Ph H2), 7.94 (d, 2H, Pz H3), 8.31 (s, 2H, Py H3/5), 9.04 (d, 2H, Pz H5). 13C 
NMR ({CD3}2SO) δ 55.8, 55.9 (both 1C, OCH3), 106.3 (1C, Ph C2), 108.2 (2C, Py C3/5), 109.1 (2C, Pz C4), 
111.8 (1C, Ph C6), 112.9 (1C, Ph C5), 128.5 (2C, Pz C5), 142.7 (1C, Ph C3), 143.4 (2C, Pz C3), 143.8 (1C, Py 
C4), 147.0 (1C, Ph C4), 149.3 (1C, Ph C1), 150.5 (2C, Py C2/6), 162.7 (1C, COOR). 
3.2.2. Synthesis of 3,4-dihydroxyphenyl 2,6-di(pyrazol-1-yl)pyridine-4-carboxylate (L4) 
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L3 (1.56 g, 4 mmol) was dissolved in dry dichloromethane (40 cm3) under nitrogen. The reaction 
mixture was cooled to ‒78 °C, and boron tribromide (4 cm3, 42.2 mmol) was added dropwise. The 
stirred solution was then heated to reflux for 4 hr, yielding an orange solution which was cooled in 
ice water. Water (20 cm3) was added dropwise to the solution, and red and white precipitates were 
collected separately, washed with water, dried on the filter, then washed with dichloromethane. 
Recrystallization of the two solids from acetone in each case yielded off-white powders, which 
proved to be the same compound L4 by 1H NMR. Yield: 1.01 g, 69%. Mp: 257–258 °C. HR-ES MS m/z 
364.1041 (calculatedd for [(C18H13N5O4)H]+ 364.0991), 386.0865 (calculated for [(C18H13N5O4)Na]+ 
386.0860). 1H NMR ({CD3}2SO) δ 6.64 (dd, 1H, Ph H6), 6.71 (pseudo-t, 2H, Pz H4), 6.77 (d, 1H, Ph H2), 
6.82 (d, 1H, Ph H5), 7.95 (d, 2H, Pz H3), 8.29 (s, 2H, Py H3/5), 9.04 (d, 2H, Pz H5), 9.34 (br s, 2H, OH). 13C 
NMR ({CD3}2SO) δ 108.2 (2C, Py C3/5), 109.0 (2C, Pz C4), 109.3 (1C, Ph C2), 111.6 (1C, Ph C6), 115.3 (1C, 
Ph C5), 128.5 (2C, Pz C5), 142.4 (1C, Ph C3), 142.8 (1C, Py C4), 143.4 (2C, Pz C3), 147.0 (1C, Ph C4), 145.8 
(1C, Ph C1), 150.5 (2C, Py C2/6), 162.7 (1C, COOR). 
3.2.3. Synthesis of benzyl 2,6-di(pyrazol-1-yl)pyridine-4-carboxylate (L5) 
A mixture of bppCOOH (1.00 g, 3.92 mmol), N,N-dicyclohexyl carbodiimide (DCC; 1.78 g, 8.62 
mmol), benzyl alcohol (0.42 g (3.92 mmol), and a catalytic amount of dimethylaminopyridine 
(DMAP) in dichloromethane (50 cm3) was stirred for 2 days under a CaCl2 tube. The resultant 
precipitate was removed, and the yellow filtrate was evaporated to dryness. Recrystallization of the 
solid residue from acetonitrile/ethyl acetate yielded an almost pure compound, which was further 
purified by a short silica chromatography column (1:1 hexane:ethyl acetate eluent) which yielded the 
product as colourless plate-like crystals. Yield: 0.25 g, 19%. Mp: 120–121 °C. HR-ES MS m/z 346.1302 
(calculated for [(C19H15N5O2)H]+ 346.1299), 368.1130 (calculated for [(C19H15N5O2)Na]+ 368.1118). 1H 
NMR (CDCl3) δ 5.44 (s, 2H, CH2), 6.52 (pseudo-t, 2H, Pz H4), 7.39 (m, 2H, Ph H2/6), 7.48 (m, 3H, Ph H3-
5), 7.79 (d, 2H, Pz H3), 8.41 (s, 2H, Py H3/5), 8.56 (d, 2H, Pz H5). 13C NMR (CDCl3) δ 68.0 (1C, CH2), 108.6 
(2C, Pz C4), 109.4 (2C, Py C3/5), 127.4 (2C, Pz C5), 128.8 (2C, Ph C3/5), 128.9 (1C, Ph C4), 128.9 (2C, Ph 
C2/6), 135.3 (1C, Ph C1), 143.0 (2C, Pz C3), 143.5 (1C, Py C4), 145.8 (1C, Ph C1), 151.0 (2C, Py C2/6), 164.1 
(1C, COOR). 
3.2.4. Synthesis of 4-methoxybenzyl 2,6-di(pyrazol-1-yl)pyridine-4-carboxylate (L6) 
Method was as for L5 using 4-methoxybenzyl alcohol (0.54 g, 3.92 mmol). The crude product 
from the initial reaction mixture was purified by flash silica column chromatography (1:1 
hexane:ethyl acetate eluent) and obtained as a white crystalline powder. Yield: 0.22 g, 15%. Mp: 151–
153 °C. HR-ES MS m/z 376.1402 (calculated for [(C20H17N5O3)H]+ 376.1404), 398.1223 (calculated for 
[(C20H17N5O3)Na]+ 398.1224). 1H NMR (CDCl3) δ 3.82 (s, 3H, OCH3), 5.37 (s, 2H, CH2), 6.51 (pseudo-t, 
2.0 Hz, 2H, Pz H4), 6.93 (d, 2H, Ph H3-5), 7.42 (d, 2H, Ph H2/6), 7.78 (d, 1.8 Hz, 2H, Pz H3), 8.38 (s, 2H, Py 
H3/5), 8.55 (d, 2.6 Hz, 2H, Pz H5). 13C NMR (CDCl3) δ 55.5 (OCH3), 67.9 (1C, CH2), 108.5 (2C, Pz C4), 
109.4 (2C, Py C3/5), 114.2 (2C, Ph C3/5), 127.4 (2C, Pz C5), 127.4 (1C, Ph C1), 130.8 (2C, Ph C2/6), 143.0 (2C, 
Pz C3), 143.6 (1C, Py C4), 150.9 (2C, Py C2/6), 160.1 (1C, Ph C4), 164.1 (1C, COOR). 
3.2.5. Synthesis of 3,4-dimethoxybenzyl 2,6-di(pyrazol-1-yl)pyridine-4-carboxylate (L7) 
Method was as for L5, using bppCOOH (1.10 g, 4.31 mmol), DCC (1.96 g, 9.48 mmol), 3,4-
dimethoxybenzyl alcohol (0.73 g, 4.31 mmol), and a catalytic amount of DMAP. The crude product 
was recrystallized from hot acetonitrile, affording a white polycrystalline powder. Yield: 1.20 g, 69%. 
Mp: 130–131 °C. HR-ES MS m/z 406.1507 (calculated for [(C21H19N5O4)H]+ 406.1510), 428.1335 
(calculated for [(C20H17N5O3)Na]+ 428.1329), 833.2764 (calculated for [(C20H17N5O3)2Na]+ 833.2766). 1H 
NMR (CDCl3) δ 3.78, 3.79 (both s, 3H, 2xOCH3), 5.35 (s, 2H, CH2), 6.65 (pseudo-t, 2.0 Hz, 2H, Pz H4), 
7.01 (d, 1H, Ph H5), 7.07 (dd, 1H, Ph H6), 7.15 (d, 1H, Ph H2), 7.89 (d, 2H, Pz H3), 8.13 (s, 2H, Py H3/5), 
8.96 (d, 2H, Pz H5). 13C NMR (CDCl3) δ 55.5 (2C, 2xOCH3), 67.7 (1C, CH2), 107.8 (2C, Py C3/5), 108.9 
(2C, Pz C4), 111.7 (1C, Ph C2), 112.7 (1C, Ph C5), 121.6 (2C, Ph C6), 127.4 (1C, Ph C1), 128.4 (2C, Pz C5), 
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143.0 (1C, Py C4), 143.2 (2C, Pz C3), 148.7, 149.1 (both 1C, Ph C3 and C4), 150.4 (2C, Py C2/6), 163.3 (1C, 
COOR). 
3.2.6. Synthesis of [Fe(L3)2][BF4]2.  
Filtered solutions of L3 (39 mg, 0.10 mmol) and Fe[BF4]2·6H2O (17 mg, 0.050 mmol) in 
nitromethane (7.5 cm3) were mixed at room temperature. The resultant solution was filtered and 
concentrated to ca. one-third its original volume. Slow diffusion of diethyl ether vapour into the 
solution yielded prismatic crystals of α-[Fe(L3)2][BF4]2·2CH3NO2, which were often contaminated by 
yellow plates of the β-[Fe(L3)2][BF4]2·2CH3NO2 polymorph. Yield: 32 mg, 63%. Found C, 47.3; H, 3.48; 
N, 13.6 %. Calculated for C40H34B2F8FeN10O8 C, 47.5; H, 3.39; N, 13.8%. 1H NMR (CD3CN) δ 3.90 (12H, 
OCH3), 7.10 (6H; Ph H2, H5 and H6), 23.2, 26.4 (both 4H, Pz H3 and H4), 39.6, 40.4 (both 4H, Pz H5 and 
Py H3/5). 
3.2.7. Synthesis of [Fe(L4)2][BF4]2 
Filtered solutions of L4 (0.16 g, 0.46 mmol) and Fe[BF4]2·6H2O (0.075 g, 0.22 mmol) in acetone (10 
cm3) were mixed at room temperature. The resultant solution was filtered and concentrated to ca. 
one-third its original volume. Slow diffusion of diethyl ether vapour into the solution yielded the 
product as a dark red powder. Recrystallization from acetonitrile/diethyl ether afforded single 
crystals of the complex. While the crystal used for X-Ray analysis was apparently solvent-free, 
microanalysis of the bulk material was more consistent with a dihydrate formulation. Yield: 42 mg, 
20%. Found C, 43.4; H, 2.59; N, 13.7%. Calculated for C36H26B2F8FeN10O8·2H2O C, 43.6; H, 3.05; N, 
14.1%. 1H NMR (CD3CN) δ 6.89 (2H), 6.99 (4H; Ph H2, H5 and H6), 7.25, 7.37 (both br s, 2H, OH), 23.1, 
26.0 (both 4H, Pz H3 and H4), 39.8, 40.3 (both 4H, Pz H5 and Py H3/5). 
3.2.8. Synthesis of [Fe(L5)2][BF4]2 
Method as for [Fe(L4)2][BF4]2, using L5 (0.10 g, 0.27 mmol) and Fe[BF4]2·6H2O (0.55 g, 0.14 mmol) 
in acetone (6 cm3). Crystals of the product obtained from the reaction mixture were well formed but 
diffracted poorly. Recrystallization of the complex from acetonitrile/diethyl ether yielded solvate 
crystals [Fe(L5)2][BF4]2·3/2CH3CN, which were suitable for crystallographic characterization. Yield: 
0.097 g, 75%. Found C, 49.5; H, 3.17; N, 15.1%. Calculated for C38H30B2F8FeN10O4 C, 49.6; H, 3.29; N, 
15.2%. 1H NMR (CD3CN) δ 5.66 (4H, CH2), 7.48 (2H, Ph H4), 7.54, 7.73 (both 4H, Ph H2/6 and H3/5), 20.2, 
23.7 (both 4H, Pz H3 and H4), 35.4, 36.9 (both 4H, Pz H5 and Py H3/5). 
3.2.9. Synthesis of [Fe(L6)2][BF4]2 
Method as for [Fe(L4)2][BF4]2, using L6 (0.10 g, 0.27 mmol) and Fe[BF4]2·6H2O (0.50 g, 0.13 mmol). 
The red product was recrystallized from acetonitrile/diethyl ether for crystallographic 
characterization. Yield: 0.10 g, 78%. Found C, 48.9; H, 3.61; N, 14.1%. Calculated for C40H34B2F8FeN10O6 
C, 49.0; H, 3.50; N, 14.3%. 1H NMR (CD3CN) δ 3.84 (6H, OCH3), 5.57 (4H, CH2), 7.07 and 7.64 (both 
4H, Ph H2/6 and H3/5), 21.4, 24.9 (both 4H, Pz H3 and H4), 38.3, 40.1 (both 4H, Pz H5 and Py H3/5).  
3.2.1.0 Synthesis of [Fe(L7)2][BF4]2 
Method as for [Fe(L4)2][BF4]2, using L7 (0.20 g, 0.49 mmol) and Fe[BF4]2·6H2O (0.93 g, 0.25 mmol). 
Diffusion of diethyl ether vapour into the concentrated solution yielded red prismatic crystals. Yield: 
0.10 g, 38%. Found C, 48.4; H, 3.72; N, 13.3%. Calculated for C42H38B2F8FeN10O8 C, 48.5; H, 3.68; N, 
13.5%. 1H NMR (CD3CN) δ 3.86 (12H, OCH3), 5.55 (4H, CH2), 7.04 (2H), 7.26 (4H; Ph H2, H5 and H6), 
21.3, 24.7 (both 4H, Pz H3 and H4), 37.1 (8H, Pz H5 and Py H3/5).  
3.3. Crystal structure determinations.  
Experimental data for the crystal structures are listed in Tables 3 and 4. Diffraction data for L5, 
L6, and L7·1/2MeCN were collected at station I19 of the Diamond synchrotron ( = 0.6889 Å). The other 
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crystals were measured with an Agilent Supernova dual-source diffractometer using 
monochromated Cu-K ( = 1.5418 Å) or Mo-K ( = 0.7107 Å) radiation. The experimental details of 
the structures determinations in this study are given in Tables 3 and 4. All the structures were solved 
by direct methods (SHELXS97 [60]), and developed by full least-squares refinement on F2 (SHELXL97 
[60]). Crystallographic figures were prepared using XSEED [61], while the VOh FeN6 coordination 
volumes were calculated using OLEX2 [62]. 
CCDC-1884419 (L3), CCDC-1884420 (L5), CCDC-1884421 (L6), CCDC-1884422 (L7·1/2MeCN), 
CCDC-1884423 (-[Fe(L3)2][BF4]2·2MeNO2), CCDC-1884424 (-[Fe(L3)2][BF4]2·2MeNO2), CCDC-
1884425 ([Fe(L4)2][BF4]2), CCDC-1884426 ([Fe(L5)2][BF4]2·3/2MeCN), and CCDC-1884427 
([Fe(L6)2][BF4]2·3/2MeCN) contain the supplementary crystallographic data for this paper. These data 
can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
Table 3 Experimental details for the organic ligand crystal structures in this work. 
Compound L3 L5 L6 L7·1/2MeCN 
formula C20H17N5O4 C19H15N5O2 C20H17N5O3 C22H20.5N5.5O4 
Mr 391.39 345.36 375.39 425.94 
crystal class monoclinic monoclinic orthorhombic monoclinic 
space group P21/c Pc Pbca P21/c 
a / Å 11.9677(2) 7.2833(1) 42.4116(3) 8.0803(1) 
b / Å 20.7834(4) 7.7290(1) 11.4438(1) 65.5346(6) 
c / Å 7.3138(1) 29.9811(5) 7.2071(1) 7.6027(1) 
 / ° 90.900(2) 92.924(1) ‒ 91.061(1) 
V / Å3 1818.93(5) 1685.52(4) 3497.96(6) 4025.24(8) 
Z 4 4 8 8 
T / K 120(2) 100(2) 100(2) 100(2) 
Dcalcd / Mgm−3 1.429 1.361 1.426 1.406 
μ / mm−1 0.855[a] 0.093[b] 0.100[b] 0.100[b] 
measured reflections 7444 25320 50109 62089 
unique reflections 3524 7820 8534 18798 
observed reflections  3020 4902 6291 12124 
Rint 0.026 0.102 0.091 0.056 
R1 [Fo>4σ(Fo)][c] 0.042 0.070 0.054 0.063 
wR2 [all data][d] 0.113 0.192 0.162 0.174 
GoF 1.038 0.992 1.021 1.034 
Flack parameter ‒ ‒0.5(12)[e] ‒ ‒ 
Δρmax, Δρmin / eÅ−3 0.31/‒0.21 0.34/‒0.44 0.80/‒0.35 0.56/‒0.42 
[a] Collected with Cu-K radiation; [b] Collected with synchrotron radiation; [c] R = [Fo –Fc] / Fo [d] 
wR = [w(Fo2 – Fc2) / wFo4]1/2; [e] The absolute structure of this light-atom crystal could not be determined. 
Unless otherwise stated, all crystallographically ordered non-H atoms in the structures 
described below were refined anisotropically, and H atoms were placed in calculated positions and 
refined using a riding model. Disordered BF4‒ ions were modelled using refined B‒F and F…F 
distance restraints, while fixed distance restraints were applied to disordered solvent molecules. 
3.3.1. Organic ligand crystallographic refinements. 
The asymmetric unit of L5 contains two unique molecules of the compound while that of 
L7·1/2MeCN contains two molecules of L7 and one acetonitrile molecule. All the H atoms in L3, L6, and 
L7·1/2MeCN were located in the Fourier map and refined positionally, with Uiso constrained to 1.5x 
Ueq of the corresponding C atom for methyl group H atoms, or to 1.2x Ueq{C} for other H atoms. H 
atom positions were not refined for L5, because of the lower data:parameter ratio in that refinement. 
While the L5 crystal adopts a handed space group, its absolute structure could not be 
unambiguously determined owing to its light atom composition. Hence, the Friedel opposite 
reflections in this dataset were merged for the final least squares refinement cycles. 
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Table 4 Experimental details for the metal complex crystal structures in this work. 
Compound α-[Fe(L3)2][BF4]2·-2MeNO2 β-[Fe(L3)2][BF4]2·-2MeNO2 [Fe(L4)2][BF4]2 
formula C42H40B2F8FeN12O12 C42H40B2F8FeN12O12 C36H26B2F8FeN10O8 
Mr 1134.33 1134.33 956.14 
crystal class triclinic triclinic triclinic 
space group P  P  P  
a / Å 8.3230(2) 11.3601(9) 8.6675(3) 
b / Å 12.8302(2) 13.2652(13) 16.8378(6) 
c / Å 23.1765(6) 17.5490(15) 27.0770(11) 
 / ° 88.116(2) 67.671(9) 85.102(3) 
 / ° 80.270(2) 80.155(7) 82.500(3) 
 / ° 89.567(2) 78.463(8) 87.451(3) 
V / Å3 2438.00(9) 2383.6(4) 3901.3(3) 
Z 2 2 4 
T / K 120(2) 120(2) 120(2) 
Dcalcd / Mgm−3 1.545 1.580 1.628 
μ / mm−1 3.412[a] 3.490[a] 4.048[a] 
measured reflections 42688 18126 59552 
unique reflections 9491 8979 15161 
observed reflections  9123 6467 10540 
Rint 0.035 0.065 0.075 
R1 [Fo>4σ(Fo)][c] 0.048 0.068 0.073 
wR2 [all data][d] 0.134 0.186 0.218 
GoF 1.066 1.049 1.030 
Δρmax, Δρmin / eÅ−3 1.30/‒0.85 0.71/‒0.84 0.85/‒0.61 
Compound [Fe(L5)2][BF4]2·3/2MeCN [Fe(L6)2][BF4]2·3/2MeCN  
formula C41H34.5B2F8FeN11.5O4 C43H38.5B2F8FeN11.5O6  
Mr 981.77 1041.82  
crystal class triclinic monoclinic  
space group P  P21/c  
a / Å 13.8965(6) 27.4401(4)  
b / Å 17.0836(7) 16.5615(3)  
c / Å 20.8001(7) 20.5281(2)  
 / ° 95.020(3) ‒  
 / ° 102.703(3) 100.257(1)  
 / ° 113.133(4) ‒  
V / Å3 4345.8(3) 9179.9(2)  
Z 4 8  
T / K 150(2) 150(2)  
Dcalcd / Mgm−3 1.501 1.508  
μ / mm−1 0.438[b] 3.466[a]  
measured reflections 46531 77065  
unique reflections 20799 17911  
observed reflections  13895 15370  
Rint 0.037 0.051  
R1 [Fo>4σ(Fo)][c] 0.067 0.080  
wR2 [all data][d] 0.170 0.220  
GoF 1.032 1.033  
Δρmax, Δρmin / eÅ−3 1.02/‒0.59 1.25/‒0.97  
[a] Collected with Cu-K radiation. [b] Collected with Mo-K radiation. [c] R = [Fo –Fc] / Fo.  
[d] wR = [w(Fo2 – Fc2) / wFo4]1/2. 
3.3.2. Crystallographic refinement of α-[Fe(L3)2][BF4]2·2MeNO2 
One of the BF4‒ ions is disordered over two sites, with refined occupancies of 0.59:0.41. One 
nitromethane molecule is also disordered, and was refined over two orientations with the same 
1 1 1
1
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occupancy ratio, but shares a common wholly occupied N atom. The highest residual Fourier peak 
of +1.3 eÅ‒3 lies within the disordered anion. 
3.3.3. Crystallographic refinement of β-[Fe(L3)2][BF4]2·2MeNO2 
One of the BF4‒ ions is disordered over three equally populated sites. 
3.3.4. Crystallographic refinement of [Fe(L4)2][BF4]2 
The asymmetric unit contains two crystallographically unique complex dications labelled ‘A’ 
and ‘B’; three whole BF4‒ anions; and, two BF4‒ half-anion sites close to crystallographic inversion 
centres. The dihydroxyphenyl substituent C(48B)-O(55B) is badly disordered and was refined over 
three sites with occupancies of 0.5:0.25:0.25 (the C3-hydroxyl O atom in orientation 'D' is further 
disordered over two equally occupied sites). These disordered phenyl groups were refined as rigid 
hexagons and with the fixed restraint C‒O = 1.37(2) Å. One of the whole BF4‒ ions, and both of the 
half-anions, are also disordered over two or three sites. 
3.3.5. Crystallographic refinement of [Fe(L5)2][BF4]2·3/2MeCN 
The asymmetric unit contains two unique complex dications, four BF4‒ anions and three 
molecules of acetonitrile. One benzyl substituent in each complex molecule was refined as 
disordered, both over two sites with a 0.6:0.4 occupancy ratio. The partial phenyl groups associated 
with this disorder were refined as rigid hexagons. Two of the anions are also disordered, one over 
two equally occupied sites and the other over three orientations with occupancies 0.60, 0.15, and 0.25; 
the first two of these share a common 0.75-occupied B atom. All fully occupied non-H atoms, plus F 
atoms with occupancy ≥0.5, were refined anisotropically. 
3.3.6. Crystallographic refinement of [Fe(L6)2][BF4]2·3/2MeCN 
The asymmetric unit of this crystal also contains two formula units of the compound. That is, 
two complex dications, four BF4‒ anions, and three molecules of acetonitrile. Two of the anions are 
disordered, one over two equally occupied sites and the other over two orientations by rotation about 
a B‒F bond with occupancies of 0.75 and 0.25. The highest residual Fourier peak of +1.3 eÅ‒3 lies 
within one of the disordered anions. 
4. Conclusions 
Five new phenyl or benzyl 2,6-di(pyrazol-1-yl)pyridine-4-carboxylate esters have been 
synthesized and complexed to iron(II). The two polymorphs α- and -[Fe(L3)2][BF4]2·2MeNO2 are 
noteworthy as rare examples of high-spin and low-spin polymorphs of the same iron complex [63]. 
This reflects the presence of similar populations of both spin states in solutions of the complex at 
room temperature (Figure 7) which, unusually, crystallize as separate crystal forms. The –
polymorph is trapped in its high-spin state by its twisted coordination geometry, which is 
significantly distorted from idealized D2d symmetry. While that is a common feature of high-spin 
[Fe(bpp)2]2+ derivatives [24], the separate crystallization of weakly distorted low-spin and strongly 
distorted high-spin polymorphs of the same complex has only been observed once before in this 
metal/ligand system [64]. 
The spin state properties of α-[Fe(L3)2][BF4]2·2MeNO2 and most of the other complexes in this 
work resemble those of [Fe(L1)2][BF4]2, [Fe(L2)2][BF4]2 [43] and other iron complexes of 2,6-di(pyrazol-
1-yl)pyridine-4-carboxylate ester ligands [29,37,44–46]. That is, they are fully or predominantly low-
spin at lower temperature but show the onset of gradual SCO on warming past room temperature. 
The exception is [Fe(L5)2][BF4]2, which exhibits a more abrupt, hysteretic spin-transition near room 
temperature after recrystallization from acetone solution. Although this phase was not 
crystallographically characterised, it indicates that more cooperative SCO switching can be obtained 
with benzyl 2,6-di(pyrazol-1-yl)pyridine-4-carboxylate esters compared to their phenyl ester 
counterparts. 
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A feature of the crystal structures in this work is the regular occurrence of two unique molecules 
in the crystallographic asymmetric units. Thus, the crystal structures of L5, L7·1/2MeCN, and all the 
complexes [FeL2][BF4]2 (L = L4-L7) exhibit Z’ = 2. The structure of [Fe(L4)2][BF4]2 is distinct from the 
others since the feature distinguishing its two unique complex cations is the presence or absence of 
sterically imposed disorder of a phenyl ester substituent. In the other cases, the crystallographically 
unique molecules show the presence or absence of ligand disorder to a similar extent but often differ 
in the conformations in their benzyl ester substituents. That implies the added flexibility of benzyl 
methylene linker in L5–L7 contributes to this structural complexity. Be that as it may, there is clear 
potential for novel SCO structure:function properties in the iron/benzyl 2,6-di(pyrazol-1-yl)pyridine-
4-carboxylate system which we are continuing to pursue in our current work.  
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